Literature DB >> 27567047

Improved production of trans-4-hydroxy-l-proline by chromosomal integration of the Vitreoscilla hemoglobin gene into recombinant Escherichia coli with expression of proline-4-hydroxylase.

Tong-Xin Zhao1, Mei Li2, Xiang Zheng2, Cheng-Hua Wang2, Hong-Xin Zhao3, Chong Zhang4, Xin-Hui Xing2.   

Abstract

trans-4-Hydroxy-l-proline (Hyp) is a chiral amino acid conventionally produced by acid hydrolysis of animal collagen, a process which involves the bottleneck problems of low efficiency and heavy environmental pollution. Biotransformation of l-proline into Hyp using recombinant whole-cell biocatalysis with proline-4-hydroxylase (P4H) is an environmentally-friendly alternative method. Since biohydroxylation of proline by whole cells is a high-oxygen-demand process, oxygen transfer needs to be improved. To solve this problem, the Vitreoscilla hemoglobin gene (vgb) was integrated into the chromosome of recombinant Escherichia coli expressing the P4H gene originally from Dactylosporangium sp. RH1. Expression of Vitreoscilla hemoglobin (VHb) resulted in a 94.4% increase of Hyp production in a 100-mL shaking flask culture compared to the same strain without VHb expression. Meanwhile in a fed-batch fermentation with a 1.4 L bioreactor, the expression of VHb led to an increase in Hyp production by 73.2% and biomass improved by 106%. We also found that acetic acid concentration was decreased by the expression of VHb during the fermentation. This work demonstrates that vgb chromosomal integration is an efficient way to improve Hyp production by enhancing oxygen transfer in recombinant E. coli.
Copyright © 2016 The Society for Biotechnology, Japan. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Biocatalysis; Escherichia coli; Fermentation; Vitreoscilla hemoglobin; trans-4-Hydroxy-l-proline

Mesh:

Substances:

Year:  2016        PMID: 27567047     DOI: 10.1016/j.jbiosc.2016.07.018

Source DB:  PubMed          Journal:  J Biosci Bioeng        ISSN: 1347-4421            Impact factor:   2.894


  8 in total

1.  Enzymatic production of trans-4-hydroxy-l-proline by proline 4-hydroxylase.

Authors:  Xiulai Chen; Juyang Yi; Jia Liu; Qiuling Luo; Liming Liu
Journal:  Microb Biotechnol       Date:  2020-07-03       Impact factor: 5.813

2.  Hydrolysing the soluble protein secreted by Escherichia coli in trans-4-hydroxy-L-proline fermentation increased dissolve oxygen to promote high-level trans-4-hydroxy-L-proline production.

Authors:  Xiaocui Liu
Journal:  Bioengineered       Date:  2019-12       Impact factor: 3.269

Review 3.  Metabolic engineering strategy for synthetizing trans-4-hydroxy-L-proline in microorganisms.

Authors:  Zhenyu Zhang; Pengfu Liu; Weike Su; Huawei Zhang; Wenqian Xu; Xiaohe Chu
Journal:  Microb Cell Fact       Date:  2021-04-21       Impact factor: 5.328

4.  Indirect Pathway Metabolic Engineering Strategies for Enhanced Biosynthesis of Hyaluronic Acid in Engineered Corynebacterium glutamicum.

Authors:  Yan Du; Fangyu Cheng; Miaomiao Wang; Chunmeng Xu; Huimin Yu
Journal:  Front Bioeng Biotechnol       Date:  2021-12-20

5.  Enhanced production of poly-γ-glutamic acid via optimizing the expression cassette of Vitreoscilla hemoglobin in Bacillus licheniformis.

Authors:  Qing Zhang; Yaozhong Chen; Lin Gao; Jian'gang Chen; Xin Ma; Dongbo Cai; Dong Wang; Shouwen Chen
Journal:  Synth Syst Biotechnol       Date:  2022-01-27

Review 6.  Oxygenating Biocatalysts for Hydroxyl Functionalisation in Drug Discovery and Development.

Authors:  Sacha N Charlton; Martin A Hayes
Journal:  ChemMedChem       Date:  2022-05-02       Impact factor: 3.540

7.  Modular reconstruction and optimization of the trans-4-hydroxy-L-proline synthesis pathway in Escherichia coli.

Authors:  Zhenyu Zhang; Weike Su; Yunyun Bao; Qianqian Huang; Kai Ye; Pengfu Liu; Xiaohe Chu
Journal:  Microb Cell Fact       Date:  2022-08-11       Impact factor: 6.352

8.  Chassis engineering of Escherichia coli for trans-4-hydroxy-l-proline production.

Authors:  Xiulai Chen; Juyang Yi; Wei Song; Jia Liu; Qiuling Luo; Liming Liu
Journal:  Microb Biotechnol       Date:  2020-05-12       Impact factor: 5.813

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.